Cargando…
High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis
BACKGROUND: Regulatory T (T(reg)) cells are implicated in the development and progression of eosinophilic granulomatosis with polyangiitis (EGPA). We previously showed beneficial effects of intravenous immunoglobulin (IVIG) therapy combined with corticosteroid and immunosuppressant treatment on clin...
Autores principales: | Tsurikisawa, Naomi, Saito, Hiroshi, Oshikata, Chiyako, Tsuburai, Takahiro, Akiyama, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417532/ https://www.ncbi.nlm.nih.gov/pubmed/25937899 http://dx.doi.org/10.1186/2045-7022-4-38 |
Ejemplares similares
-
An increase of CD83(+) dendritic cells ex vivo correlates with increased regulatory T cells in patients with active eosinophilic granulomatosis and polyangiitis
por: Tsurikisawa, Naomi, et al.
Publicado: (2014) -
Th17 cells reflect colon submucosal pathologic changes in active eosinophilic granulomatosis with polyangiitis
por: Tsurikisawa, Naomi, et al.
Publicado: (2015) -
Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother
por: Ueki, Yuriko, et al.
Publicado: (2019) -
Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi
por: Adachi, Sei, et al.
Publicado: (2022) -
Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis
por: Masumoto, Nami, et al.
Publicado: (2023)